Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
First-in-Human Evaluation of Safety, Pharmacokinetics and Muscle Glycogen Lowering of a Novel Glycogen Synthase 1 Inhibitor for the Treatment of Pompe Disease.
Journal: Clinical pharmacology and therapeutics
Published: May 10, 2024
Phase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic Impairment.
Journal: European journal of drug metabolism and pharmacokinetics
Published: July 31, 2022
Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties.
Journal: Clinical pharmacology and therapeutics
Published: June 06, 2018
Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations.
Journal: Circulation. Heart failure
Published: December 16, 2016
Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction.
Journal: Circulation. Heart failure
Published: October 21, 2016
Case 3: Respiratory distress in a 3-month-old boy.
Journal: Pediatrics in review
Published: February 04, 2015
Human stem cells from single blastomeres reveal pathways of embryonic or trophoblast fate specification.
Journal: Development (Cambridge, England)
Published: January 30, 2015
MicroRNA-363 negatively regulates the left ventricular determining transcription factor HAND1 in human embryonic stem cell-derived cardiomyocytes.
Journal: Stem cell research & therapy
Published: January 20, 2014
Last Updated: 09/26/2026